Bone Mineral Density Loss in People With Epilepsy Taking Valproate as a Monotherapy: A Systematic Review and Meta-Analysis

Overview of attention for article published in Frontiers in Neurology, November 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (83rd percentile)
Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

news: 1 news outlet

twitter: 6 X users

Citations

dimensions_citation: 13 Dimensions

Readers on

mendeley: 21 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 1 news story.

Bone Mineral Density Loss in People With Epilepsy Taking Valproate as a Monotherapy: A Systematic Review and Meta-Analysis

MyNeuroNews, 08 Nov 2019

Objective: Data on changes in bone mineral density (BMD) from valproate (VPA) therapy are ambiguous and conflicting.

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.